https://www.selleckchem.com/products/shikonin.html
The objective of this study was to develop a novel prognostication model in patients with treatment-naïve metastatic renal cell carcinoma (mRCC). This study included 325 consecutive mRCC patients receiving first-line molecular-targeted therapy at 4 institutions. Potential parameters associated with overall survival (OS) in these patients were investigated to develop a novel stratification model. Median OS of the 325 patients was 38 months. A multivariable analysis of several factors identified independent predictors associated with unf
Like
Comment
Share